DFPG Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$3.03M Buy
29,246
+3,064
+12% +$303K 0.24% 106
2023
Q3
$2.62M Buy
26,182
+3,706
+16% +$326K 0.24% 105
2023
Q2
$1.8M Buy
22,476
+3,800
+20% +$310K 0.16% 135
2023
Q1
$1.49M Buy
18,676
+1,220
+7% +$86.5K 0.16% 138
2022
Q4
$1.16M Buy
+17,456
New +$1.02M 0.19% 124

Other funds holding NVO

DFPG Investments's NVO Position: Q4 2023 in Review

DFPG Investments increased its Novo Nordisk (NVO) stake by 12% in Q4 2023, buying an estimated $303K and bringing the position to 29,246 shares worth $3.03M. The position accounts for 0.24% of the portfolio, ranked #106.

DFPG Investments first reported a position in NVO in Q4 2022 and has held it in 5 quarters since. 1,511 funds tracked by Wall St. Rank hold NVO as of Q4 2023.

  • DFPG Investments held 29,246 shares of Novo Nordisk worth $3.03M as of Q4 2023.
  • DFPG Investments bought 3,064 Novo Nordisk shares in Q4 2023, an estimated $303K.
  • Novo Nordisk made up 0.24% of DFPG Investments's portfolio in Q4 2023, its #106 holding.
  • DFPG Investments first reported a position in Novo Nordisk in Q4 2022 and has held it in 5 quarters since.
  • 1,511 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2023.

Based on DFPG Investments's 13F filing for Q4 2023, filed 10 Jan 2024.